Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Novel cystine derivatives inhibit stone formation in vivo

Nov. 7, 2014

Nymox's NX-1207 fails to achieve efficacy endpoints in phase III BPH trials

Nov. 3, 2014

Relypsa submits NDA to FDA seeking approval of patiromer for hyperkalemia

Oct. 23, 2014

Cardiotrophin-1 granted FDA orphan designation for use in kidney transplantation

Oct. 22, 2014

Fispemifene licensed to Apricus Biosciences

Oct. 21, 2014

Topline results reported from phase IIa study of LPCN-1111

Oct. 14, 2014

Patient enrollment under way in phase II trial of VPI-2690B in diabetic nephropathy

Oct. 9, 2014

Scientists at Roche synthesize novel autotaxin inhibitors

Oct. 9, 2014

DiscoveryBioMed receives grant for ADPKD drug development

Oct. 8, 2014

Linagliptin as potential treatment for uremic calcification

Oct. 3, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...